The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age

J Urol. 1992 Mar;147(3 Pt 2):837-40. doi: 10.1016/s0022-5347(17)37400-1.

Abstract

We estimated the in vivo prostate gland volume in 408 men (320 without clinical evidence of prostate cancer, and 88 with an abnormal digital rectal examination and/or transrectal prostate ultrasound and negative biopsies) using sequential step-section ultrasound analysis and correlated it to the serum prostate specific antigen (PSA) value. Of the men 331 (81.1%) had a PSA value of 4 ng./ml. or less. The PSA value was greater than 4 but less than or equal to 10 in 64 men (15.7%) and greater than 10 in 13 (3.2%). The men were subclassified by prostate gland volume at arbitrary break points. A total of 139 men (34.1%) had a gland of 25 cm.3 or less, 2.2% of whom had a PSA value of greater than 4. Further analysis revealed that the incidence of a PSA value greater than 4 increased as the prostate volume increased (18.4% for greater than 25 but less than or equal to 50, and 65.4% for greater than 50) and as age increased. We found a statistically significant association between prostate gland volume and patient age (p less than 0.00005) to the serum PSA concentration. The finding of a PSA value of greater than 10 was uncommon regardless of the prostate gland volume. Clinical implications of these results are discussed, and a statistical model to estimate the serum PSA by gland volume and patient age was constructed.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm / blood*
  • Biomarkers, Tumor / blood*
  • Humans
  • Male
  • Middle Aged
  • Prostate / diagnostic imaging
  • Prostate / pathology
  • Prostate-Specific Antigen
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnostic imaging
  • Regression Analysis
  • Ultrasonography

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Prostate-Specific Antigen